Skip to main content

Arcutis Biotherapeutics, Inc.

ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001787306

In the last 90 days, Arcutis Biotherapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 272 institutions reported holding it in 13F filings for Q2 2026, worth $3.45B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Arcutis Biotherapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
12 filings
5 insiders, $2.30M in total
Insiders trading
5
Net value
−$2.30M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Arcutis Biotherapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Arcutis Biotherapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Matsuda MasaruSee Remarks112,508Sep 18, 20269
Welgus Howard G.Director35,841Sep 17, 202613
Curran TerrieDirector23,526Aug 28, 20263
Burnett PatrickSee Remarks117,592Aug 21, 202612
Watanabe Todd FranklinSee Remarks717,203Aug 5, 20268
Peetz ChristopherDirector4,315Jul 17, 20261
Lin Sue-JeanDirector27,567Jun 17, 20263
Heron Patrick JDirector32,213Jun 12, 20261
Leonard Keith RDirector27,901Jun 9, 20263
Gilbert Halley EDirector27,901Jun 9, 20262
Munshi AmitDirector9,799Jun 9, 20262
Krishnamohan NehaDirector27,901Jun 9, 20262
Vairavan LathaSVP Chief Financial Officer85,978May 13, 20265
Edwards Larry ToddSee Remarks175,178Mar 3, 20264
Chaudhuri BhaskarDirector867,826Jun 16, 20250
Topper David JosephChief Financial Officer182,774Apr 3, 20250
Moore Matthew RichardSVP and Chief Business Officer145,505May 3, 20240
Smither John WChief Financial Officer11,365Feb 15, 20240
Topper James N10% Owner8,764,232Oct 26, 20230
Frazier Life Sciences VIII, L.P.10% Owner8,764,232Oct 26, 20230
FHM Life Sciences VIII, L.P.10% Owner8,764,232Oct 26, 20230
FHM Life Sciences VIII, L.L.C.10% Owner8,764,232Oct 26, 20230
Osborne David WChief Technical Officer268,854Mar 8, 20230
Turney Patricia A.SVP, Operations62,862Mar 8, 20230
Lock Kenneth A.Chief Commercial Officer63,429Mar 8, 20230
Burrows Scott LChief Financial Officer59,115Mar 8, 20230
OrbiMed Advisors LLC10% Owner415,142IndirectJun 28, 20220
OrbiMed Capital LLC10% Owner415,142IndirectJun 28, 20220
OrbiMed Capital GP VII LLC10% Owner415,142IndirectJun 28, 20220
Turner Joseph LDirector4,312Jun 3, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 5, 2025 (view filing)Aug 41 dayVairavan LathaSVP Chief Financial OfficerSSale−89$14.33−$1.28K−0.1%65.0K after10b5-1
Aug 5, 2025 (view filing)Aug 41 dayBurnett PatrickSee RemarksSSale−2.62K$14.33−$37.6K−2.3%112.8K after10b5-1
Aug 5, 2025 (view filing)Aug 41 dayWatanabe Todd FranklinSee RemarksSSale−11.5K$14.33−$165.5K−1.3%901.6K after10b5-1
Aug 12, 2025 (view filing)Aug 84 daysBurnett PatrickSee RemarksSSale−3.85K$14.03−$54.0K−3.4%109.0K after10b5-1
Aug 21, 2025 (view filing)Aug 19-212 daysBurnett PatrickSee RemarksSSale−4.19K$15.82−$66.2K−3.8%104.8K after2 lots10b5-1
Sep 4, 2025 (view filing)Sep 22 daysWelgus Howard G.DirectorSSale−10.0K$15.64−$156.4K−9.1%100.2K after10b5-1
Sep 8, 2025 (view filing)Sep 44 daysMatsuda MasaruSee RemarksSSale−36.1K$16.16−$583.9K−18.3%161.2K after10b5-1
Sep 10, 2025 (view filing)Sep 8-92 daysWatanabe Todd FranklinSee RemarksSSale−10.1K$17.54−$177.7K−1.1%891.4K after2 lots10b5-1
Oct 3, 2025 (view filing)Oct 12 daysWelgus Howard G.DirectorSSale−10.0K$18.92−$189.2K−9.1%99.7K after2 lots10b5-1
Oct 3, 2025 (view filing)Oct 1-22 daysWatanabe Todd FranklinSee RemarksSSale−45.0K$19.66−$884.7K−5.0%846.4K after3 lots10b5-1
Oct 6, 2025 (view filing)Oct 24 daysEdwards Larry ToddSee RemarksSSale−4.50K$20.04−$90.3K−2.5%179.3K after2 lots10b5-1
Oct 30, 2025 (view filing)Oct 282 daysWatanabe Todd FranklinSee RemarksSSale−40.0K$25.03−$1.00M−4.7%806.4K after10b5-1
Nov 5, 2025 (view filing)Nov 3-52 daysBurnett PatrickSee RemarksSSale−6.49K$24.12−$156.5K−6.2%98.3K after3 lots10b5-1
Nov 5, 2025 (view filing)Nov 32 daysMatsuda MasaruSee RemarksSSale−7.21K$24.71−$178.1K−4.5%154.0K after2 lots10b5-1
Nov 5, 2025 (view filing)Nov 32 daysWelgus Howard G.DirectorSSale−10.0K$25.27−$252.7K−10.0%89.7K after10b5-1
Nov 5, 2025 (view filing)Nov 32 daysWatanabe Todd FranklinSee RemarksSSale−11.5K$24.71−$285.4K−1.4%794.9K after2 lots10b5-1
Nov 5, 2025 (view filing)Nov 32 daysVairavan LathaSVP Chief Financial OfficerSSale−88$24.72−$2.18K−0.1%64.9K after10b5-1
Nov 10, 2025 (view filing)Nov 64 daysBurnett PatrickSee RemarksSSale−17.3K$24.18−$417.1K−14.9%98.3K after10b5-1
Nov 10, 2025 (view filing)Nov 64 daysEdwards Larry ToddSee RemarksSSale−29.1K$25.16−$732.9K−16.2%150.2K after
Nov 17, 2025 (view filing)Nov 134 daysKrishnamohan NehaDirectorSSale−40.5K$23.20−$939.5K−64.7%22.1K after2 lots10b5-1
Nov 21, 2025 (view filing)Nov 201 dayGilbert Halley EDirectorSSale−16.5K$27.55−$455.5K−42.8%22.1K after
Nov 21, 2025 (view filing)Nov 192 daysMatsuda MasaruSee RemarksSSale−2.55K$28.29−$72.1K−1.7%151.5K after2 lots10b5-1
Nov 24, 2025 (view filing)Nov 21-243 daysWatanabe Todd FranklinSee RemarksSSale−50.0K$30.35−$1.52M−6.3%740.5K after2 lots10b5-1
Nov 25, 2025 (view filing)Nov 241 dayLin Sue-JeanDirectorSSale−25.3K$30.78−$777.9K−48.6%26.7K after
Dec 3, 2025 (view filing)Dec 12 daysMatsuda MasaruSee RemarksSSale−1.66K$30.23−$50.1K−1.1%150.6K after10b5-1
Dec 3, 2025 (view filing)Dec 12 daysWelgus Howard G.DirectorSSale−10.0K$30.21−$302.1K−11.1%79.7K after10b5-1
Dec 17, 2025 (view filing)Dec 152 daysBurnett PatrickSee RemarksSSale−11.5K$28.94−$332.8K−10.5%98.3K after10b5-1
Jan 2, 2026 (view filing)Dec 31, 20252 daysBurnett PatrickSee RemarksSSale−1.70K$29.21−$49.6K−1.7%96.6K after2 lots10b5-1
Jan 6, 2026 (view filing)Jan 24 daysWelgus Howard G.DirectorSSale−10.0K$28.96−$289.6K−12.5%69.7K after10b5-1
Jan 7, 2026 (view filing)Jan 52 daysBurnett PatrickSee RemarksSSale−2.49K$28.98−$72.2K−2.6%94.1K after10b5-1
Feb 4, 2026 (view filing)Feb 22 daysEdwards Larry ToddSee RemarksSSale−2.05K$25.50−$52.3K−1.4%148.9K after10b5-1
Feb 4, 2026 (view filing)Feb 22 daysWelgus Howard G.DirectorSSale−10.0K$25.05−$250.5K−14.3%59.7K after10b5-1
Feb 4, 2026 (view filing)Feb 22 daysVairavan LathaSVP Chief Financial OfficerSSale−1.32K$25.50−$33.7K−2.0%63.6K after10b5-1
Feb 4, 2026 (view filing)Feb 22 daysWatanabe Todd FranklinSee RemarksSSale−19.8K$25.50−$505.7K−2.7%721.3K after10b5-1
Feb 4, 2026 (view filing)Feb 2-42 daysBurnett PatrickSee RemarksSSale−13.5K$25.73−$346.5K−14.3%80.7K after2 lots10b5-1
Feb 4, 2026 (view filing)Feb 22 daysMatsuda MasaruSee RemarksSSale−40.6K$25.28−$1.03M−27.0%110.0K after4 lots10b5-1
Mar 3, 2026 (view filing)Mar 21 dayBurnett PatrickSee RemarksSSale−6.29K$25.18−$158.3K−4.9%121.2K after2 lots10b5-1
Mar 3, 2026 (view filing)Mar 21 dayVairavan LathaSVP Chief Financial OfficerSSale−2.85K$25.18−$71.8K−3.1%87.8K after2 lots10b5-1
Mar 3, 2026 (view filing)Feb 27-Mar 24 daysMatsuda MasaruSee RemarksSSale−12.1K$26.03−$313.9K−8.1%136.9K after4 lots10b5-1
Mar 3, 2026 (view filing)Mar 21 dayWatanabe Todd FranklinSee RemarksSSale−37.3K$25.18−$940.5K−4.5%786.0K after2 lots10b5-1
Mar 3, 2026 (view filing)Mar 21 dayEdwards Larry ToddSee RemarksSSale−3.69K$25.18−$92.8K−2.1%175.2K after2 lots10b5-1
Mar 4, 2026 (view filing)Mar 22 daysWelgus Howard G.DirectorSSale−10.0K$25.65−$256.5K−16.7%49.7K after10b5-1
Mar 4, 2026 (view filing)Mar 22 daysLeonard Keith RDirectorSSale−39.3K$25.39−$997.1K−64.0%22.1K after10b5-1
Apr 3, 2026 (view filing)Apr 12 daysWelgus Howard G.DirectorSSale−10.0K$23.88−$238.8K−20.1%39.7K after10b5-1
May 5, 2026 (view filing)May 14 daysWelgus Howard G.DirectorSSale−7.14K$22.99−$164.2K−18.0%32.6K after10b5-1
May 6, 2026 (view filing)May 42 daysBurnett PatrickSee RemarksSSale−684$23.61−$16.1K−0.6%120.5K after10b5-1
May 6, 2026 (view filing)May 42 daysMatsuda MasaruSee RemarksSSale−8.26K$23.31−$192.4K−6.1%126.7K after2 lots10b5-1
May 6, 2026 (view filing)May 42 daysWatanabe Todd FranklinSee RemarksSSale−3.17K$23.61−$74.9K−0.4%720.8K after10b5-1
May 6, 2026 (view filing)May 42 daysVairavan LathaSVP Chief Financial OfficerSSale−1.34K$23.61−$31.7K−1.5%86.4K after10b5-1
May 13, 2026 (view filing)May 112 daysBurnett PatrickSee RemarksSSale−222$21.05−$4.67K−0.2%120.2K after10b5-1